2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Patient Satisfaction
2
Urologic Neoplasms
1
Thyroid Cancer, Papillary
1
Sarcoma, Ewing
1
Sarcoma
1
Radiation Injuries
1
Patient Preference
1
Patient Acceptance of Health Care
1
Osteosarcoma
1
Osteitis Deformans
1
Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Radiotherapy
38
Radiotherapy, Intensity-Modulated
12
Cisplatin
12
Amifostine
11
Paclitaxel
7
Carboplatin
7
Radiosurgery
6
Etoposide
5
Brachytherapy
5
Surgical Procedures, Operative
4
Low-Level Light Therapy
4
Donepezil
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sargramostim
3
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Neuropsychological Tests
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Heavy Ion Radiotherapy
3
Filgrastim
3
Diet Therapy
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Lithium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Injuries
×
delta 24-sterol reductase
×
Clear all
NCT04590976
2023-02-08
IP5-MATTER
Imperial College London
Completed
320 enrolled